Physician

Yevgeniy Vladimirovich Sychev, M.D.

According to 2025 Medicare claims, Yevgeniy Sychev, M.D. (NPI: 1609166768) practices ophthalmology in the Minneapolis-St. Paul-Bloomington, MN-WI market, with the plurality of this provider's patient population coming from Ramsey, MN. This provider's primary affiliated billing organization is VITREO RETINAL SURGERY PLLC (NPI: 1891783965; TIN: 411608615) and primary practice location at 56001-4877.

Sychev's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 726 traditional Medicare patients, billed 18,529 HCPCS/CPT codes, and received $2,336,668 in Medicare payments. The top billing code was J0178 (Injection, aflibercept, 1 mg). Part D data shows 675 prescription claims across 232 beneficiaries totaling $23,502 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 17 records totaling $156,840. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $5,650 to $2,336,668. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $6,020 to $23,502. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.2M$2.3M2015 Medicare payment: $5,650 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $53,032 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $70,671 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $66,553 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $450,927 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $620,059 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $935,403 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $1,083,304 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $2,002,730 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $2,336,668 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
201567111$5,650
2016106311$53,032
2017132538$70,671
2018154640$66,553
20194363,882$450,927
20205094,693$620,059
20215916,293$935,403
20226426,373$1,083,304
202380913,655$2,002,730
202472618,529$2,336,668

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$14K$27K2015 Drug cost: $6,020 (USD; Tot_Drug_Cst)2016 Drug cost: $7,123 (USD; Tot_Drug_Cst)2017 Drug cost: $3,391 (USD; Tot_Drug_Cst)2018 Drug cost: $5,732 (USD; Tot_Drug_Cst)2019 Drug cost: $17,525 (USD; Tot_Drug_Cst)2020 Drug cost: $19,285 (USD; Tot_Drug_Cst)2021 Drug cost: $24,156 (USD; Tot_Drug_Cst)2022 Drug cost: $25,754 (USD; Tot_Drug_Cst)2023 Drug cost: $27,360 (USD; Tot_Drug_Cst)2024 Drug cost: $23,502 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201540128$6,020
201654116$7,123
201755113$3,391
201870177$5,732
2019160463$17,525
2020138457$19,285
2021176585$24,156
2022221623$25,754
2023253657$27,360
2024232675$23,502

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
J0178Injection, aflibercept, 1 mg1441,548$656
67028Injection of drug into eye3131,489$97
92014Established patient complete exam of visual system304347$83
92012Established patient problem focused exam of visual system378762$69
92134Imaging of retina7002,236$31

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Prednisolone AcetatePrednisolone Acetate27812,328$14,778
Ketorolac TromethamineKetorolac Tromethamine702,416$1,689
ValacyclovirValacyclovir Hcl14567$1,165
TobramycinTobramycin1172,375$649
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat393,227$628

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.0$0N/R
Research PaymentsReported research-related payment or transfer-of-value amount.17$156,840Genentech, Inc.
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Yevgeniy Vladimirovich Sychev, M.D.?

Tedicare shows public-source Medicare data for Yevgeniy Vladimirovich Sychev, M.D. (NPI 1609166768), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Yevgeniy Vladimirovich Sychev, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Yevgeniy Vladimirovich Sychev, M.D.?

Yevgeniy Vladimirovich Sychev, M.D. is linked to VITREO RETINAL SURGERY PLLC (billing NPI 1891783965) in the available physician profile data.

Does Yevgeniy Vladimirovich Sychev, M.D. have Open Payments data?

Yevgeniy Vladimirovich Sychev, M.D. has 17 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.